Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : Chondrocytes
Therapeutic Area : Musculoskeletal
Study Phase : Undisclosed
Recipient : Mundipharma
Deal Size : Undisclosed
Deal Type : Agreement
Mundipharma, Biosolution to market CartiLife in South Korea
Details : Under the agreement, Mundipharma obtains the rights to market and distribute CartiLife® in South Korea.
Brand Name : Undisclosed
Molecule Type : Cell and Gene therapy
Upfront Cash : Undisclosed
January 06, 2020
Lead Product(s) : Chondrocytes
Therapeutic Area : Musculoskeletal
Highest Development Status : Undisclosed
Recipient : Mundipharma
Deal Size : Undisclosed
Deal Type : Agreement
LOOKING FOR A SUPPLIER?